These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 3322393

  • 1. Possible involvement of the A20-A21 peptide bond in the expression of the biological activity of insulin. 1. [21-Desasparagine,20-cysteinamide-A]insulin and [21-desasparagine,20-cysteine isopropylamide-A]insulin.
    Chu YC, Wang RY, Burke GT, Chanley JD, Katsoyannis PG.
    Biochemistry; 1987 Nov 03; 26(22):6966-71. PubMed ID: 3322393
    [Abstract] [Full Text] [Related]

  • 2. Possible involvement of the A20-A21 peptide bond in the expression of the biological activity of insulin. 3. [21-Desasparagine,20-cysteine ethylamide-A]insulin and [21-desasparagine,20-cysteine 2,2,2-trifluoroethylamide-A]insulin.
    Chu YC, Wang RY, Burke GT, Chanley JD, Katsoyannis PG.
    Biochemistry; 1987 Nov 03; 26(22):6975-9. PubMed ID: 3322395
    [Abstract] [Full Text] [Related]

  • 3. Possible involvement of the A20-A21 peptide bond in the expression of the biological activity of insulin. 2. [21-Asparagine diethylamide-A]insulin.
    Chu YC, Burke GT, Chanley JD, Katsoyannis PG.
    Biochemistry; 1987 Nov 03; 26(22):6972-5. PubMed ID: 3322394
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. An insulin analogue possessing higher in vitro biological activity than receptor binding affinity. [21-Proline-B]insulin.
    Schwartz GP, Burke GT, Chanley JD, Katsoyannis PG.
    Biochemistry; 1983 Sep 13; 22(19):4561-7. PubMed ID: 6354263
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Photoaffinity labeling of insulin receptor with an insulin analogue selectively modified at the amino terminal of the B chain.
    Yeung CW, Moule ML, Yip CC.
    Biochemistry; 1980 May 13; 19(10):2196-203. PubMed ID: 6990974
    [No Abstract] [Full Text] [Related]

  • 9. Nature of the B10 amino acid residue. Requirements for high biological activity of insulin.
    Burke GT, Schwartz G, Katsoyannis PG.
    Int J Pept Protein Res; 1984 Apr 13; 23(4):394-401. PubMed ID: 6373642
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Studies on the total synthesis of an A7,B7-dicarbainsulin. III. Assembly of segments and generation of biological activity.
    Videnov G, Büttner K, Casaretto M, Föhles J, Gattner HG, Stoev S, Brandenburg D.
    Biol Chem Hoppe Seyler; 1990 Nov 13; 371(11):1057-66. PubMed ID: 2085412
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of insulin fragments on biological activity of insulin and desoctapeptide insulin. II. Enhanced binding and mechanism studies.
    Kikuchi K, Larner J, Freer RJ, Day AR.
    J Biol Chem; 1981 Sep 25; 256(18):9445-9. PubMed ID: 7026554
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A highly potent insulin: des-(B26-B30)-[AspB10,TyrB25-NH2]insulin(human).
    Schwartz GP, Burke GT, Katsoyannis PG.
    Proc Natl Acad Sci U S A; 1989 Jan 25; 86(2):458-61. PubMed ID: 2643113
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Synthesis of an insulin analogue embodying a strongly fluorescent moiety, [19-tryptophan-A]insulin.
    Ohta N, Burke GT, Katsoyannis PG.
    J Protein Chem; 1988 Feb 25; 7(1):55-65. PubMed ID: 3076448
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.